Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosus

Jyoti Bakshi1, Sara C Croca1, Maura Griffin2,3

  • 1Centre for Rheumatology Research, Division of Medicine, University College London.

Insights

Vascular plaque burden in patients with Systemic Lupus Erythematosus (SLE) predicts cardiovascular disease (CVD) risk. Increased plaque in multiple sites and total plaque area significantly elevate CVD event likelihood in SLE patients.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Medical Imaging

Background:

  • Systemic Lupus Erythematosus (SLE) patients exhibit a higher prevalence of cardiovascular disease (CVD) and subclinical atherosclerosis.
  • While vascular plaque is common in SLE patients, its total burden's impact on subsequent CVD risk is not well-established.

Purpose of the Study:

  • To investigate the relationship between the total burden of vascular plaque and the risk of developing future CVD events in patients with SLE.
  • To identify specific plaque characteristics that may serve as predictors of CVD in this population.

Main Methods:

  • One hundred SLE patients without prior CVD underwent vascular ultrasound scans of carotid and femoral arteries.
  • Baseline clinical, serological, demographic, and treatment data were collected.
  • Patients were followed up to 2020 for new-onset coronary disease or stroke; statistical analysis identified CVD risk factors.

Main Results:

  • Thirty-six patients had baseline plaque; 7 developed CVD events (5 with plaque, 2 without).
  • Having plaque in three or more bifurcations increased CVD risk tenfold (OR 9.9, P=.009).
  • Total plaque area (TPA) > 16mm² (OR 6.44, P=.028) and disease duration > 14 years (OR 8.3, P=.043) were associated with increased CVD risk.

Conclusions:

  • The number of plaque-affected bifurcations and total plaque area in SLE patients are valuable for assessing CVD risk.
  • These plaque burden metrics can aid in clinical decision-making for CVD risk reduction strategies in SLE management.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
125
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
138
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
57
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
49
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
51
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
44